Clinical studies recruiting near Changde

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Phase 3 · The First People's Hospital of Changde City · Capital Medical University · NCT06548971 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness
NA · The First Principle Hospital of Changde City · IBSA Farmaceutici Italia Srl · NCT06914583 Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Phase 3 · Research Site · AstraZeneca · NCT06079671 Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Phase 3 · The First People's Hospital of Changde City · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07107256 Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT）
Phase 3 · the First People's Hospital of Changde · Capital Medical University · NCT06559241 The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
Phase 2 · The First People's Hospital of Changde City · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06452706 Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma
NA · Changde First People's Hospital · Beijing Tiantan Hospital · NCT07144423 Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases
NA · Changde Hospital, Xiangya school of Medicine, Central South · Fudan University · NCT07469267 A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Brea
Phase 3 · The First PEOPLE'S HOSPITAL OF CHANGDE CITY · Jiangsu Simcere Pharmaceutical Co., Ltd. · NCT06680921 TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Phase 3 · The First People's Hospital of Changde City · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07047365 Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Phase 3 · Research Site · AstraZeneca · NCT06467357 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a
Phase 3 · Research Site · AstraZeneca · NCT07000357 A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensiti
Phase 3 · The First People's Hospital of Changde City · Eli Lilly and Company · NCT07213804 A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a
Phase 3 · Changde Second People's Hospital · Boehringer Ingelheim · NCT06935370 A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer
Phase 3 · The First People's Hospital of Changde City · Eli Lilly and Company · NCT07174336 A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Phase 2 · The First People's Hospital of Changde City · Eli Lilly and Company · NCT07169851 A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Phase 3 · Changde Second People's Hospital · Boehringer Ingelheim · NCT06424288 Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · Changde First People's Hospital · Eli Lilly and Company · NCT07157774 A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Bili
Phase 3 · Research Site · AstraZeneca · NCT07221253 Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
Phase N/A · Changde Hospital, Xiangya School of Medicine, Central South · Sun Yat-sen University · NCT06551220 Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Phase 2 · The First People's Hospital of Changde · Kylonova (Xiamen) Biopharma co., LTD. · NCT07327840 BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Phase 3 · General Hospital of Hunan University of Medicine · Staidson (Beijing) Biopharmaceuticals Co., Ltd · NCT07168161 PM8002 in the Treatment of Patients With Advanced Solid Tumors
Phase 1/Phase 2 · Changde First People's Hospital · Biotheus Inc. · NCT05918445 JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Phase 3 · The First People's Hospital of Changde · Jiangsu Alphamab Biopharmaceuticals Co., Ltd · NCT06079983 Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Phase 3 · Research Site · AstraZeneca · NCT06677060 ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Phase 3 · Changde First People's Hospital · BioNTech SE · NCT07173751 Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy
Phase 2 · The First People's Hospital of Changde · Shanghai Junshi Bioscience Co., Ltd. · NCT06924606 A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and
Phase 3 · Changde First People's Hospital · Eli Lilly and Company · NCT07241390 Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Meta
Phase 3 · Research Site · AstraZeneca · NCT07431281

Look up another city

Look up another condition